ABOUT: Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. Pfizer Inc - PFE - reported that the FDA has granted approval of the Company’s pneumococcal conjugate vaccine Prevnar 13 for the Prevention of Pneumococcal Pneumonia and Invasive Disease in Adults 50 Years and Older. Pneumococcal disease, including pneumonia, in adults 50 years and older represents a significant personal and societal health burden in the United States. Pfizer is committed to applying science and its global resources to improve health and well-being at every stage of life. hanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Shalika Jayasekera